Create Account
Log In
Dark
chart
exchange
Premium
Terminal
Screener
Stocks
Crypto
Forex
Trends
Depth
Close
Check out our Dark Pool Levels

AMRX
Amneal Pharmaceuticals, Inc. Class A Common Stock
stock NASDAQ

At Close
Jul 29, 2026 3:59:57 PM EDT
19.11USD+1.866%(+0.35)1,962,428
0.00Bid   0.00Ask   0.00Spread
Pre-market
Jul 29, 2026 9:29:30 AM EDT
18.86USD+0.533%(+0.10)911
After-hours
Jul 29, 2026 4:59:30 PM EDT
19.40USD+1.518%(+0.29)7,400
OverviewOption ChainMax PainOptionsHistoricalExchange VolumeDark Pool LevelsDark Pool PrintsExchangesShort VolumeShort Interest - DailyShort InterestBorrow Fee (CTB)Failure to Deliver (FTD)ShortsTrendsNewsNews
Jan 5, 2022
08:20AM EST  The Daily Biotech Pulse: Pfizer-BioNTech Partner For Shingles Vaccine, Annexon Huntington Disease Study Disappoints, Amneal Buys Neurology Assets   Benzinga
07:39AM EST  Wednesday, Amneal Pharmaceuticals Inc. (AMRX) announced that it is acquiring privately-held Saol Therapeutics' Baclofen franchise, a move that will expand its neurology presence into spasticity.   RTTNews
06:21AM EST  Amneal To Buy Saol's Baclofen Franchise; Transaction To Close In Q1   RTTNews
06:08AM EST  Amneal Acquires Saol Therapeutics' Baclofen Franchise; Terms Not Disclosed   Benzinga
06:05AM EST  Amneal Acquires Saol Therapeutics' Baclofen Franchise   Business Wire
Dec 21, 2021
08:00AM EST  Amneal to Virtually Participate at the 40th Annual J.P. Morgan Healthcare Conference   Business Wire
Dec 17, 2021
04:21PM EST  Amneal Pharma Form 4 Filings Show 2 Co CEOs Purchased 150K Shares Each, Exec VP Sold 2K Shares   Benzinga
Dec 8, 2021
09:06AM EST  TherapeuticsMD, Amneal Settle US Patent Litigation For Bijuva   Benzinga
08:19AM EST  The Daily Biotech Pulse: Valneva Strikes Deal To Supply COVID Vaccine to Bahrain, TherapeuticsMD & Amneal Settle Patent Lawsuit, Reata Awaits Adcom   Benzinga
06:55AM EST  UPDATE: As Part Of Settlement, TherapeuticsMD Granted To Amneal A License To Commercialize Amneal's Generic Version Of BIJUVA In US, Commencing May 25, 2032   Benzinga
Nov 19, 2021
08:52AM EST  Amneal Pharmaceuticals Inc. (AMRX), a generics and specialty pharmaceutical company, on Friday, said it has received FDA approval for Difluprednate ophthalmic emulsion 0.05 percent, the generic version of Durezol, which is used in the treatment of inflammation and pain associated with ocular surgery.   RTTNews
08:09AM EST  Amneal Pharma Receives ANDA Approval For Difluprednate Ophthalmic Emulsion   RTTNews
08:03AM EST  Amneal Pharma Reports Receives Approval For Difluprednate Ophthalmic Emulsion   Benzinga
08:00AM EST  Amneal Receives Approval for Difluprednate Ophthalmic Emulsion   Business Wire
Nov 12, 2021
08:00AM EST  Amneal to Virtually Participate at Upcoming Investor Conferences   Business Wire
Nov 3, 2021
09:19AM EDT  The Daily Biotech Pulse: Cerus Climbs On Earnings, Horizon CFO To Retire, Teva Prices Upsized Sustainability-Linked Senior Note Offering   Benzinga
09:13AM EDT  Amneal Raises FY21 EPS Guidance From $0.70-$0.85 To $0.78-$0.88 Vs. $0.88 Est.; Cuts FY21 Sales Guidance From $2.1B-$2.2B To ~$2.1B Vs. $2.14B Est.   Benzinga
09:13AM EDT  Amneal Pharmaceuticals Q3 EPS $0.21 Beats $0.20 Estimate, Sales $528.59M Miss $545.06M Estimate   Benzinga
09:10AM EDT  Earnings Scheduled For November 3, 2021   Benzinga
06:13AM EDT  Amneal Pharmaceuticals Q3 Loss/shr Narrows To $0.03 From $0.06 Last Year   RTTNews
06:00AM EDT  Amneal Reports Third Quarter 2021 Financial Results   Business Wire
Nov 2, 2021
08:00AM EDT  Amneal Releases Inaugural Corporate Responsibility Report Highlighting Our Impact as a Socially Responsible Company   Business Wire
Oct 31, 2021
02:24PM EDT  The Week Ahead In Biotech (Oct. 31-Nov. 6): Earnings Pick Up Pace, Eton Awaits Seizure Drug Approval, Kidney Conference, More IPOs In The Pipeline   Benzinga
Oct 27, 2021
05:18PM EDT  Amneal Pharmaceuticals Granted Tentative Approval For PLERIXAFOR   Benzinga
08:12AM EDT  Amneal Launches Generic Dexamethasone Following ANDA Approval by FDA   Benzinga
Oct 25, 2021
11:55AM EDT  Mark Cuban-Owned Company To Launch Pharmacy Benefit Management Services   Benzinga
Oct 6, 2021
08:00AM EDT  Amneal to Report Third Quarter 2021 Results on November 3, 2021   Business Wire
Sep 28, 2021
12:21AM EDT  Blackhawk's MindBio Therapeutics Utilizes Trip Pharma to Bring Microdosing Trials to North America   Benzinga
Sep 8, 2021
05:32PM EDT  Blackhawk Growth Closes Investment in Psychedelic and Wellness Company MindBio Therapeutics Pty Ltd.   Benzinga
Sep 7, 2021
08:00AM EDT  Amneal to Virtually Participate at Morgan Stanley 19th Annual Global Healthcare Conference   Business Wire
Sep 5, 2021
12:21AM EDT  Blackhawk Growth to Complete Investment in Psychedelic and Wellness Company MindBio Therapeutics Pty Ltd.   Benzinga
Aug 26, 2021
08:09AM EDT  The Daily Biotech Pulse: Early Approval For Ascendis' Pediatric Growth Hormone Deficiency Treatment, Redhill Biopharma Spikes On Positive COVID-19 Drug Data, RenovoRx IPO   Benzinga
Aug 25, 2021
04:03PM EDT  Amneal Announces Topline Results From Pivotal Phase 3 RISE-PD Clinical Trial Of IPX-203 In Patients With Parkinson's Disease Who Experience Motor Fluctuations   Benzinga
04:01PM EDT  Amneal Announces Positive Topline Results from Pivotal Phase 3 RISE-PD Clinical Trial of IPX-203 in Patients with Parkinson's Disease Who Experience Motor Fluctuations   Business Wire
07:30AM EDT  The Daily Biotech Pulse: Lilly Strikes $1.6B R&D Collaboration, FSD Pulls Plug On COVID-19 Program, Cassava Sinks On Questions About Alzheimer's Drug   Benzinga
Aug 23, 2021
08:05AM EDT  Amneal Pharmaceuticals Announces Virtual Event To Discuss Initial Data From Pivotal Phase 3 Study Of IPX-203 In Patients with Parkinson's Disease Who Experience Motor Fluctuations   Benzinga
08:00AM EDT  Amneal Announces Virtual Event to Discuss Initial Data from Pivotal Phase 3 Study of IPX-203 in Patients with Parkinson's Disease Who Experience Motor Fluctuations   Business Wire
Aug 11, 2021
12:56PM EDT  Amneal Pharmaceuticals Granted Labeling Approval For 'ESTRADIOL; NORETHINDRONE ACETATE'   Benzinga
Aug 9, 2021
11:07AM EDT  The Week Ahead In Biotech (Aug. 8-14): Jazz Pharma FDA Decision, Earnings Deluge and IPOs In The Spotlight   Benzinga
07:41AM EDT  Amneal Q2 Earnings Tops Estimates; Backs FY21 Guidance   Benzinga
07:07AM EDT  Amneal Pharmaceuticals: Q2 Earnings Insights   Benzinga
06:21AM EDT  Amneal Pharma Q2 EPS $0.10; Adj EPS $0.25   RTTNews
06:12AM EDT  Amneal Pharmaceuticals Reaffirms FY21 Guidance; Sees Adj. EPS $0.70-$0.85 vs $0.82 Est., Sales $2.1B-$2.2B vs $2.12B Est.   Benzinga
06:11AM EDT  Amneal Pharmaceuticals Q2 Adj. EPS $0.25 Beats $0.19 Estimate, Sales $535.00M Beat $523.25M Estimate   Benzinga
06:00AM EDT  Amneal Reports Second Quarter 2021 Financial Results   Business Wire
04:11AM EDT  Earnings Scheduled For August 9, 2021   Benzinga
Aug 8, 2021
10:11AM EDT  The Week Ahead In Biotech (Aug. 8-14): Jazz Pharma FDA Decision, Earnings Deluge and IPOs In The Spotlight   Benzinga
Jul 20, 2021
08:20AM EDT  The Daily Biotech Pulse: Ardelyx Sinks On Regulatory Setback, AnPac Issues Positive Preannouncement, European Nod For Myovant, HCW Biologics Debuts On Wall Street   Benzinga
Jul 19, 2021
04:33PM EDT  Amneal Pharmaceuticals Says Receives Approval For Generic TobraDex   Benzinga
04:32PM EDT  Amneal Receives Approval for Generic TobraDex(r)   Business Wire
Jul 15, 2021
08:00AM EDT  Amneal to Report Second Quarter 2021 Results on August 9, 2021   Business Wire
Jun 17, 2021
10:32AM EDT  Amneal's Avastin-Referred Biosimilar Under FDA Review For Colorectal Cancer   Benzinga
08:14AM EDT  Amneal Pharma: FDA Accepts For Review The BLA For Bevacizumab   RTTNews
08:01AM EDT  Amneal Announces FDA Filing Acceptance Of Biologics License Application For Bevacizumab   Benzinga
08:00AM EDT  Amneal Announces U.S. FDA Filing Acceptance of Biologics License Application (BLA) for Bevacizumab   Business Wire
Jun 7, 2021
08:07AM EDT  Amneal Announces Dihydroergotamine (DHE) Autoinjector NDA For Migraines And Cluster Headaches   Benzinga
May 14, 2021
09:00AM EDT  Amneal to Virtually Participate at Upcoming Investor Conferences   Business Wire
May 7, 2021
07:40AM EDT  The Daily Biotech Pulse: Split Verdict For Chemocentryx, NKarta-CRISPR In Cell Therapy Collaboration, Orphazyme's Clinical Trial Setback, 2 IPOs   Benzinga
06:12AM EDT  Amneal Q1 EPS $0.04 Vs $0.78 Year Ago   RTTNews
06:07AM EDT  Amneal Pharmaceuticals Q1 Adj. EPS $0.20 Beats $0.18 Estimate, Adj. EBITDA $126M, Sales $493.00M Miss $515.34M Estimate; Reaffirms FY21 Guidance   Benzinga
06:00AM EDT  Amneal Reports First Quarter 2021 Financial Results   Business Wire
04:12AM EDT  Earnings Scheduled For May 7, 2021   Benzinga
May 6, 2021
10:13AM EDT  Earnings Outlook for Amneal Pharmaceuticals   Benzinga
May 3, 2021
09:49AM EDT  Overview Of Value Stocks In The Healthcare Sector   Benzinga
Apr 26, 2021
01:54PM EDT  5 Value Stocks In The Healthcare Sector   Benzinga
Apr 15, 2021
08:00AM EDT  Amneal to Report First Quarter 2021 Results on May 7, 2021   Business Wire
Apr 5, 2021
08:23AM EDT  Amneal Closes Acquisition Of Kashiv Specialty Pharma   RTTNews
08:00AM EDT  Amneal Completes Acquisition of Kashiv Specialty Pharmaceuticals   Business Wire
Mar 23, 2021
08:18AM EDT  The Daily Biotech Pulse: FDA Approvals For Merck, Pacira And Zealand, Roche-Regeneron Ace Late-Stage COVID-19 Study, AlloVir Appoints Gilead Virology Chief As CEO   Benzinga
Mar 16, 2021
08:17AM EDT  The Daily Biotech Pulse: Fulgent Nabs CDC Contract, Enzo Rallies, Solid Biosciences Releases Gene Therapy Data, Moderna Begins Pediatric Vaccine Study   Benzinga
Mar 10, 2021
07:26AM EST  The Daily Biotech Pulse: MediciNova Bags BARDA Contract, Lilly's COVID-19 Antibody Cocktail Data, Bluebird Bio Refutes Blood Cancer Link   Benzinga
Mar 8, 2021
10:04AM EST  Benzinga's Top Ratings Upgrades, Downgrades For March 8, 2021   Benzinga
09:51AM EST  5 Value Stocks In The Healthcare Sector   Benzinga
Feb 26, 2021
08:17AM EST  The Daily Biotech Pulse: Adcom Test Awaits J&J's COVID-19 Vaccine, Lilly To Supply Additional Antibody Therapy Doses To US, Regulatory Setback For Tricida   Benzinga
06:22AM EST  Amneal Pharma Q4 Adj EPS $0.14 Vs $0.08 Last Year   RTTNews
06:07AM EST  Amneal Pharma Gets Approval From FDA For 150 Mcg/day Norelgestromin, 35 Mcg/day Ethinyl Estradiol Transdermal System   RTTNews
06:05AM EST  Amneal Sees FY21 Adj. EPS $0.70-$0.85 vs $0.71 Estimate, Adj. EBITDA $500M-$540M, Sales $2.1B-$2.2B vs $2.06B Est.   Benzinga
06:04AM EST  Amneal Pharmaceuticals Q4 Adj. EPS $0.14 Beats $0.13 Estimate, Sales $510.00M Beat $507.02M Estimate   Benzinga
06:04AM EST  Amneal Pharma Reports Received Approval For Generic Version Of Ortho Evra   Benzinga
06:02AM EST  Amneal Receives Approval for Generic Version of Ortho Evra(r)   Business Wire
06:00AM EST  Amneal Reports Fourth Quarter and Full Year 2020 Financial Results   Business Wire
04:52AM EST  Earnings Scheduled For February 26, 2021   Benzinga
Feb 25, 2021
10:04AM EST  A Preview Of Amneal Pharmaceuticals's Earnings   Benzinga
Feb 22, 2021
04:05PM EST  Amneal to Virtually Participate at Upcoming Investor Conferences   Business Wire
Feb 10, 2021
07:34AM EST  The Daily Biotech Pulse: Lilly COVID-19 Antibody Cocktail Approved for Emergency Use, Gamida, Genfit Jump On Data, 2 IPOs   Benzinga
Feb 4, 2021
08:04AM EST  Amneal to Report Fourth Quarter & Full Year 2020 Results on February 26, 2021   Business Wire
Jan 12, 2021
08:16AM EST  The Daily Biotech Pulse: GSK, Vir To Start COVID-19 Antibody Study, Novartis In-Licenses BeiGene's Cancer Drug, Earnings Preannouncements Continue   Benzinga
06:21AM EST  Amneal Pharmaceuticals, Inc. (AMRX) and Kashiv BioSciences LLC have entered into a definitive agreement under which Amneal Pharmaceuticals LLC, a unit of the company, will acquire a 98% interest in Kashiv Specialty Pharmaceuticals, a subsidiary of Kashiv. Amneal expects the deal will be financially accretive by approximately $15 million of adjusted EBITDA on an annualized basis.   RTTNews
06:04AM EST  Amneal To Acquire 98% Interest In Kashiv Specialty Pharmaceuticals, LLC   RTTNews
06:03AM EST  Amneal to Acquire Substantially All Of Kashiv Specialty Pharmaceuticals; Amneal To Pay Upfront Cash Payment Of $70M And A $30M Cash Payment at One-Year-Anniversary Of Execution OF Purchase Agreement   Benzinga
06:00AM EST  Amneal to Acquire Substantially All of Kashiv Specialty Pharmaceuticals   Business Wire
Jan 8, 2021
08:08AM EST  Amneal Pharma Launches Generic Abiraterone Acetate Tablets, USP, 500 Mg, Following ANDA Approval By FDA   RTTNews
08:00AM EST  Amneal Launches Generic Abiraterone Acetate Tablets, USP, 500 mg, Following ANDA Approval by FDA   Business Wire
Jan 5, 2021
09:23AM EST  Amneal to Virtually Participate at the 39th Annual J.P. Morgan Healthcare Conference   Business Wire
Dec 14, 2020
07:45AM EST  Guggenheim Upgrades Amneal Pharmaceuticals to Buy   Benzinga
Nov 23, 2020
10:24AM EST  5 Value Stocks To Watch In The Healthcare Sector   Benzinga
Nov 16, 2020
09:48AM EST  A Look Into Healthcare Sector Value Stocks   Benzinga
Nov 11, 2020
08:39AM EST  Amneal Receives Approval For ANDA From FDA For Acyclovir Cream, 5%   RTTNews
08:38AM EST  Amneal Reports Received Abbreviated New Drug Application Approval For Acyclovir Cream, 5%   Benzinga
08:35AM EST  Amneal Receives Abbreviated New Drug Application Approval for Acyclovir Cream, 5%   Business Wire
Nov 10, 2020
02:30PM EST  Amneal Pharmaceuticals On Nov. 9 Granted FDA Approval For ACYCLOVIR   Benzinga
Nov 9, 2020
04:21AM EST  SVB Leerink Maintains Market Perform on Amneal Pharmaceuticals, Lowers Price Target to $5.5   Benzinga
Nov 6, 2020
07:53AM EST  Recap: Amneal Pharmaceuticals Q3 Earnings   Benzinga
07:47AM EST  The Daily Biotech Pulse: Novartis Drug Flunks COVID-19 Study, Molecular Templates' Blood Cancer Study Placed On Partial Hold   Benzinga
06:14AM EST  UPDATE: Amneal Pharma Raises FY20 Guidance: Adj. EPS From $0.45-$0.60 To $0.55-$0.65 vs $0.59 Estimate, Net Sales From $1.875B-$1.975B To $1.95B-$2B vs $1.93B Est.   Benzinga
06:13AM EST  Amneal Pharma Raises FY20 Guidance   Benzinga
06:12AM EST  Amneal Pharmaceuticals Q3 Adj. EPS $0.16 Beats $0.12 Estimate, Sales $519.29M Beat $482.11M Estimate   Benzinga
06:06AM EST  Amneal Q3 Adjusted EPS $0.16 Vs $0.04 Last Year   RTTNews
06:01AM EST  Amneal Reports Third Quarter 2020 Financial Results   Business Wire
03:33AM EST  Earnings Scheduled For November 6, 2020   Benzinga
Nov 5, 2020
10:08AM EST  Earnings Outlook for Amneal Pharmaceuticals   Benzinga
Nov 1, 2020
09:40AM EST  The Week Ahead In Biotech (Nov. 1-7): Adcom Test For Biogen's Aducanumab, Alzheimer's Conference, SMID-cap Earnings   Benzinga
Oct 15, 2020
08:00AM EDT  Amneal to Report Third Quarter 2020 Results on November 6, 2020   Business Wire
Oct 9, 2020
08:55AM EDT  Piper Sandler Maintains Overweight on Amneal Pharmaceuticals, Raises Price Target to $6   Benzinga
Oct 8, 2020
03:10PM EDT  Company Profile for Amneal Pharmaceuticals   Business Wire
08:00AM EDT  Amneal & PL Developments Launch Store Brand Program of Over-the-Counter ("OTC") Diclofenac Sodium Topical Gel, 1%   Business Wire
Sep 1, 2020
08:00AM EDT  Amneal to Virtually Participate at the Morgan Stanley Global Healthcare Conference   Business Wire
Aug 25, 2020
09:19AM EDT  Amneal Receives Abbreviated New Drug Application Approval For Lidocaine Patch, 5%   Benzinga
Aug 12, 2020
08:02AM EDT  WishBone Medical, Inc., a leader in pediatric orthopedic medical devices, is pleased to announce the appointment of Jeff George, global healthcare executive and investor, to the companys board of directors, effective August 12, 2020.   GlobeNewswire Inc
Aug 6, 2020
07:57AM EDT  The Daily Biotech Pulse: FDA Nod For GlaxoSmithKline, Bristol-Myers Squibb Earnings, Acutus Medical IPO   Benzinga
07:19AM EDT  Biocryst Pharmaceuticals Q2 EPS $(0.24) Beats $(0.25) Estimate   Benzinga
06:27AM EDT  Amneal Reaffirms FY20 Guidance; Sees Adj. EPS $0.45-$0.60 vs $0.56 Est., Sales $1.875B-$1.975B vs $1.91B Est.   Benzinga
06:25AM EDT  Amneal Pharmaceuticals Q2 Adj. EPS $0.13 Beats $0.10 Estimate, Sales $465.00M Beat $458.44M Estimate   Benzinga
06:22AM EDT  Amneal Pharma Q2 Loss/Class A And B1 $0.08 Vs. Loss $0.13 Last Year   RTTNews
06:01AM EDT  Amneal Reports Second Quarter 2020 Financial Results   Business Wire
Jul 27, 2020
12:12PM EDT  Goldman Sachs Initiates Coverage On Amneal Pharmaceuticals with Sell Rating, Announces Price Target of $4   Benzinga
Jul 14, 2020
07:00AM EDT  Cosette Pharmaceuticals, Inc. (Cosette or the Company), a privately held specialty generic pharmaceutical company primarily focused on extended topical and suppository products, announced today the appointment of Apurva Saraf as President and Chief Executive Officer.   GlobeNewswire Inc
Jul 13, 2020
08:30AM EDT  Phathom Pharmaceuticals Announces Appointment of Todd Branning as   GlobeNewswire Inc


Share
About
Pricing
Policies
Markets
API
Info
tz UTC-4
Connect with us
ChartExchange Email
ChartExchange on Discord
ChartExchange on X
ChartExchange on Reddit
ChartExchange on GitHub
ChartExchange on YouTube
© 2020 - 2026 ChartExchange LLC